Literature DB >> 17467241

A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer.

Elke Sadler1, Zelmira Lazarova, Pichaya Sarasombath, Kim B Yancey.   

Abstract

Anti-epiligrin cicatricial pemphigoid (AECP) is a chronic, autoimmune, subepidermal blistering disease characterized by circulating anti-basement membrane autoantibodies to laminin 5. Recent studies have shown that patients with this form of cicatricial pemphigoid have an increased relative risk for malignant solid tumors. The mechanism underlying this association of AECP and cancer is unknown, but there is accumulating evidence that laminin 5 plays a central role. In this article we report a patient with AECP and co-associated cutaneous T cell lymphoma and summarize all to date reported cases of AECP associated with malignancies. In addition we provide a review of the biology of laminin 5 and its potential role in cancer development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17467241     DOI: 10.1016/j.jdermsci.2007.02.012

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  8 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

2.  IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid.

Authors:  Zelmira Lazarova; Valerie K Salato; Christoph M Lanschuetzer; Marleen Janson; Janet A Fairley; Kim B Yancey
Journal:  J Am Acad Dermatol       Date:  2008-04-08       Impact factor: 11.527

3.  Mucous Membrane Pemphigoid-Associated Malignancies: Case Series and a Brief Overview of the Literature.

Authors:  Michelangelo La Placa; Riccardo Balestri; Federico Tartari; Andrea Sechi; Francesca Ferrara; Camilla Loi; Annalisa Patrizi; Federico Bardazzi
Journal:  Dermatol Pract Concept       Date:  2019-04-30

4.  Paraneoplastic mucous membrane pemphigoid with ocular and laryngeal involvement.

Authors:  Silvia Lambiel; Pavel Dulguerov; Emmanuel Laffitte; Igor Leuchter
Journal:  BMJ Case Rep       Date:  2017-08-11

5.  Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.

Authors:  Coralie Zumelzu; Marina Alexandre; Christelle Le Roux; Patricia Weber; Alexis Guyot; Annie Levy; Françoise Aucouturier; Sabine Mignot-Grootenboer; Frédéric Caux; Eve Maubec; Catherine Prost-Squarcioni
Journal:  Front Med (Lausanne)       Date:  2018-09-27

6.  Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases.

Authors:  F Giurdanella; A M Nijenhuis; G F H Diercks; M F Jonkman; H H Pas
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

7.  The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.

Authors:  Hua Qian; Yohei Natsuaki; Hiroshi Koga; Tamihiro Kawakami; Chiharu Tateishi; Daisuke Tsuruta; Norito Ishii; Xiaoguang Li; Takashi Hashimoto
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

8.  A Probing of the Issue of Detecting IgG, IgG4 and IgA Antibodies to Laminin 332 Epitopes in Mucous Membrane Pemphigoid: A Clinical-Laboratory Experience of a Single Central European University Dermatology Department.

Authors:  Justyna Gornowicz-Porowska; Magdalena Jałowska; Agnieszka Seraszek-Jaros; Monika Bowszyc-Dmochowska; Elżbieta Kaczmarek; Marian Dmochowski
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.